Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
Endogenous cannabinoids (ECs) are lipid-signaling molecules that specifically bind to cannabinoid receptor types 1 and 2 (CB1R and CB2R) and are highly expressed in central and many peripheral tissues under pathological conditions. Activation of hepatic CB1R is associated with obesity, insulin resis...
Main Authors: | Arulkumar Nagappan, Jooyeon Shin, Myeong Ho Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/9/2109 |
Similar Items
-
Protective Effects of Gomisin N against Hepatic Cannabinoid Type 1 Receptor-Induced Insulin Resistance and Gluconeogenesis
by: Arulkumar Nagappan, et al.
Published: (2018-03-01) -
Cannabinoid 2 Receptor Agonist Improves Systemic Sensitivity to Insulin in High-Fat Diet/Streptozotocin-Induced Diabetic Mice
by: Xiuyuan Zhang, et al.
Published: (2016-12-01) -
Effects of cannabinoid modulation on hypothalamic nesfatin-1 and insulin resistance
by: Oktay Kaya, et al.
Published: (2019-01-01) -
Cannabinoid receptors distribution in mouse cortical plasma membrane compartments
by: Hajar Miranzadeh Mahabadi, et al.
Published: (2021-06-01) -
G1359A polymorphism of the cannabinoid receptor gene (CNR1) and insulin resistance in patients with diabetes mellitus type 2 Relación del polimorfismo G1359A del receptor endocanabinoide CB1 y la resistencia a la insulina en pacientes con diabetes mellitus tipo 2
by: D. A. de Luis, et al.
Published: (2010-02-01)